# MedFocus Fund

> MedFocus Fund is a VC fund in Irvine backing Health Care and Medical Device. See 11 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Irvine, United States
- Total investments: 11
- Last investment: Jan 2019
- Lead investor: 18%
- Last updated: Aug 2026
- Website: http://fund-mgmt.com

MedFocus Fund is a VC fund in Irvine focused on Health Care and Medical Device. The MedFocus Fund is a family of private equity funds which concentrate in early-stage investments in new medical device technologies.

## Contacts

5 contacts available for MedFocus Fund. Shizune tracks 1 team members at MedFocus Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/medfocus-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 8 | 73% |
| Medical Device | 8 | 73% |
| Medical | 5 | 45% |
| Biotechnology | 5 | 45% |
| Health Diagnostics | 2 | 18% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 7 | 64% |
| Series C | 2 | 18% |
| Seed | 1 | 9% |
| Funding Round | 1 | 9% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 10 | 91% |
| Ireland | 1 | 9% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Michael M. Henson | Founder, President and CEO | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Perfuze | Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway. | $3.3M | Seed | Jan 29, 2019 |  |
| Vascular Dynamics | Vascular Dynamics, Inc. (VDI) is a privately-held company founded in 2008 by Rainbow Medical Ltd. (Rainbow). Rainbow is a healthcare accelerator developing the technologies invented by Israeli inventor, Yossi Gross. In November 2011, VDI's development and commercialization efforts were moved to Mountain View, CA.VDI has developed apassive, catheter-delivered implant for the treatment of high blood pressure, also referred to as hypertension. Collectively, the VDI team has over 75 years of experience developing and commercializing medical devices. | $16.9M | Series B | Jan 08, 2015 |  |
| Ellipse Technologies | Ellipse Technologies is focused on developing its implantable remote control technology platforms to include innovative treatments for a broad spectrum of spinal and orthopedic deformity applications, orthopedic trauma and fracture management.The initial products restore proper anatomic position and alignment of the spine and long-bones. MAGECâ„¢MAGnetic Expansion Control System utilizes a novel motion-preserving, minimally-invasive technology that, through communication with an external magnetic field, can be non-invasively adjusted in an outpatient setting via remote control by the physician to correct spinal deformities. PRECICE System uses non-invasive adjustable intramedullary rods or bone plates to treat long-bone abnormalities, often the result of acute or chronic fractures.Ellipse is a privately-held medical device company located in California. | $17.6M | Series C | Aug 02, 2011 |  |
| Reverse Medical | Reverse Medical is a commercial-stage medical device company focused on revascularizing patients experiencing Acute Ischemic Stroke. | $14M | Series B | Apr 07, 2010 |  |
| Embrella Cardiovascular | Embrella Cardiovascular, Inc. develops a system to enhance embolic cerebral protection, enabling interventionalists to reduce the frequency of embolic strokes during cardiovascular procedures. Embrella Cardiovascular, Inc. is based in Malvern, Pennsylvania. | $1.6M | Series B | Oct 01, 2009 |  |
| SpineAlign Medical | SpineAlign Medical, Inc. designs and manufactures medical devices for spinal surgery. The company is based in San Jose, California. |  |  | Jun 03, 2008 |  |
| Interventional Spine | Interventional Spine®, Inc. was founded in February 2000 to solve a key problem confronting surgeons: how to address the aging population and resulting increase of fractures in patients with osteoporotic bone? Fracture fixation devices available at the time had severe limitations when used in the presence of osteoporotic bone.InterventionalSpine product development was grounded on the basis of the Company's Compression (CLASP®) technology, which provides effective fixation in both normal and osteoporotic bone. Due to the superior fracture fixation characteristics of the CLASP® technology, Interventional Spine originally designed devices for the Podiatric and Orthopedic Trauma markets, successfully implanting over 4,000 Orthopedic Trauma Products in patients. The technology enabled surgeons to change the way they managed bone fractures, allowing for precise positioning with compression independent of thread movement, while providing superior pullout resistance and compression when compared to traditional lag screws. This proven and patented technology forms the basis of Interventional Spine's existing products. | $24M | Series C | May 31, 2007 |  |
| Bioabsorbable Therapeutics | Bioabsorbable Therapeutics, Inc. develops and commercializes medical devices for treating coronary and peripheral vascular diseases. Its products include Whisper coronary stent system, a balloon-expandable fully absorbable coronary stent; and Unison Peripheral Stent System, a self-expanding fully absorbable peripheral stent. The company usesanti-inflammatory polymers to develop bioabsorbable coatings and stents. Bioabsorbable Therapeutics, Inc. was founded in 2004 and is based in Menlo Park, California. | $9M | Series B | May 09, 2007 |  |
| MiCardia Corporation | MiCardia is a privately held medical device company currently preparing for the commercialization of its first series of products, enCor™, in the European Union. enCor is a unique device that surgically treats mitral valve regurgitation. enCor utilizes the company's patented technology, Dynaplasty™, to provide a "second chance" tothe patient who develops recurrent regurgitation. enCor can be activated to physiologically adjust the mitral valve leaflets to resolve regurgitation, minimally invasively, weeks to years later, without the need for the risk and cost of redo surgery. | $9M | Series B | Oct 17, 2006 |  |
| Triage Medical | Triage Medical Inc., an Irvine, Calif.-based developer orthopedic trauma devices. | $10M | Series B | Aug 20, 2003 |  |

10 of 11 investments shown.

## Co-investors
- [HBM Healthcare Investments](https://shizune.co/investors/profile/hbm-healthcare-investments-ag) — VC Fund, 6 deals together
- [BioStar Capital](https://shizune.co/investors/profile/biostar-private-equity) — VC Fund, 4 deals together
- Wexford Capital — VC Fund, 3 deals together
- Frantz Medical — VC Fund, 2 deals together
- [Hatteras Venture Partners](https://shizune.co/investors/profile/hatteras-venture-partners) — VC Fund, 2 deals together
- [Japan Asia Investment](https://shizune.co/investors/profile/japan-asia-investment) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does MedFocus Fund invest in?

MedFocus Fund invests primarily in Health Care, Medical Device and Medical startups, most often at Series B and Series C stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact MedFocus Fund?

Public channels for MedFocus Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at MedFocus Fund?

The team at MedFocus Fund includes Michael M. Henson (Founder, President and CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co